Literature DB >> 23576669

Recurrent erythema nodosum: a red flag sign of hidden systemic vasculitis.

Monica Gupta1, Kamal Singh, S S Lehl, Mala Bhalla.   

Abstract

Takayasu's arteritis is a rare, systemic vasculitis with varied presentations across multiple medical specialities. Here, we present a young woman who had recurrent episodes of erythema nodosum on the background of a low-grade fever and no vascular manifestations. The presence of a high erythrocyte sedimentation rate generated a high index of suspicion for underlying vasculitis, and radioimaging confirmed the suspicion of Takayasu's arteritis. The patient was found to have type III diseases in the vasculitic stage and was managed with systemic corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23576669      PMCID: PMC3645399          DOI: 10.1136/bcr-2013-009507

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Tocilizumab: a novel therapy for patients with large-vessel vasculitis.

Authors:  Carlo Salvarani; Luca Magnani; Mariagrazia Catanoso; Nicolò Pipitone; Annibale Versari; Lucia Dardani; Lia Pulsatelli; Riccardo Meliconi; Luigi Boiardi
Journal:  Rheumatology (Oxford)       Date:  2011-11-10       Impact factor: 7.580

Review 2.  Takayasu's arteritis--recent advances in imaging offer promise.

Authors:  J Andrews; J C Mason
Journal:  Rheumatology (Oxford)       Date:  2006-10-13       Impact factor: 7.580

3.  Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis.

Authors:  M E Soto; N Espinola; L F Flores-Suarez; P A Reyes
Journal:  Clin Exp Rheumatol       Date:  2008 May-Jun       Impact factor: 4.473

4.  Cutaneous manifestations of Takayasu arteritis. A retrospective study of 80 cases.

Authors:  C Francès; S Boisnic; O Blétry; A Dallot; D Thomas; E Kieffer; P Godeau
Journal:  Dermatologica       Date:  1990

Review 5.  New treatment strategies in large-vessel vasculitis.

Authors:  Sebastian Unizony; John H Stone; James R Stone
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

6.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

  6 in total
  6 in total

Review 1.  Erythema nodosum.

Authors:  Alexander K C Leung; Kin Fon Leong; Joseph M Lam
Journal:  World J Pediatr       Date:  2018-09-29       Impact factor: 2.764

2.  Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases.

Authors:  Gleice Clemente; Clovis A Silva; Silvana B Sacchetti; Virginia P L Ferriani; Sheila K Oliveira; Flavio Sztajnbok; Blanca E R G Bica; André Cavalcanti; Teresa Robazzi; Marcia Bandeira; Maria Teresa Terreri
Journal:  Rheumatol Int       Date:  2018-04-23       Impact factor: 2.631

3.  Clinical Characteristics of Patients with Erythema Nodosum and Risk of Relapse - a 17-Year Study.

Authors:  Petros Ioannou; Angeliki M Andrianaki; Dimitra Dimopoulou; Sabine Kruger-Krasagakis; Dimitra Koumaki; Diamantis P Kofteridis; George Samonis; Konstantinos Krasagakis
Journal:  Maedica (Bucur)       Date:  2022-06

Review 4.  Erythema nodosum - review of the literature.

Authors:  Małgorzata Chowaniec; Aleksandra Starba; Piotr Wiland
Journal:  Reumatologia       Date:  2016-06-03

5.  Ultrasonography as a Diagnostic Support Tool for Childhood Takayasu Arteritis Referred to as Fever of Unknown Origin: Case Series and Literature Review.

Authors:  Hisataka Nozawa; Masao Ogura; Mikiko Miyasaka; Hiromichi Suzuki; Kenji Ishikura; Akira Ishiguro; Shuichi Ito
Journal:  JMA J       Date:  2021-09-13

6.  Extravascular manifestations of Takayasu arteritis: focusing on the features shared with spondyloarthritis.

Authors:  Oh Chan Kwon; Sang-Won Lee; Yong-Beom Park; Ji Seon Oh; Sang Hoon Lee; Seokchan Hong; Chang-Keun Lee; Bin Yoo; Yong-Gil Kim
Journal:  Arthritis Res Ther       Date:  2018-07-11       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.